Gilead and Esade have presented the HUB Visionarium, a project that arises from the desire to promote innovation, research and entrepreneurship in health. Through this collaborative space of excellence, we want to promote the development of disruptive projects that offer solutions to health challenges current. Promoting the purpose of generating a positive change and having an impact on the improvement of society through the generation of knowledge and transformative science.
This year, in the first edition of Visionarium, the project will focus on innovation in HIV, a pandemic that since it appeared four decades ago has killed more than 40 million people and continues to constitute a huge social and social challenge. sanitary. Through “Accelerator Program”, Gilead will invest 180,000 euros, which will serve to develop three winning projects that provide solutions in three areas: prevention, diagnosis and referral; in people with HIV; and in the quality of HIV care.
In addition to financial aid, those responsible for these projects will participate in a mentoring program taught by experts in innovation and entrepreneurship from the Esade Entrepreneurship Institute (EEI)innovation partner of the HUB, to be able to develop your idea or project and contribute to starting it up.
In this way, Gilead wants to “make the impossible possible” and contribute both to finding solutions to the unmet needs of people with HIV, and to promoting the entrepreneurial ecosystem and economic development in Spain. “We want to encourage innovation at the service of patients suffering from serious diseases. This project tries to inspire and promote those initiatives that can offer to society, in general, and to patients, in particular, solutions that they cannot even imagine, far superior to their best expectations, and, to begin with, this first year we are going to focus on those living with HIV. Visionarium is in keeping with the spirit that pushes us to make the impossible possible in order to create a healthier and healthier world for all,” he says. María Río, Vice President and General Director of Gilead Spain.
The Visionarium launch event was attended by Teresa Riesgo, Secretary General of Innovation of the Ministry of Science and Innovationwho highlighted its commitment “to innovation and research with a strong commitment to development, but also through collaboration and communication with companies and scientific societies, two key audiences”.
Visionarium has an external committee of experts, which acts as an advisor and will be the in charge of selecting the winners of the first wave of the Accelerator Program 2023. It is made up of: Mercedes Balcells-Camps, co-founder and director of the MIT-Spain Program; Candela Calle, member of the board of directors of Sedisa; Manel Peiró, director of the Institute for Healthcare Management at EsadeGov; Jorge Garrido, executive director of Positive Support; Adrià Curran, specialist in the Infectious Service of the Vall d’Hebron Hospital; and Jesús Troya, an internist at the Infanta Leonor Hospital.